|
1
|
El Ouazzani H, Fortin S, Venisse N, Dupuis A, Rouillon S, Cambien G, Gourgues AS, Pierre-Eugène P, Rabouan S, Migeot V, Albouy-Llaty M. Perinatal Environmental Health Education Intervention to Reduce Exposure to Endocrine Disruptors: The PREVED Project. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 19:ijerph19010070. [PMID: 35010328 PMCID: PMC8750995 DOI: 10.3390/ijerph19010070] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 12/17/2021] [Accepted: 12/19/2021] [Indexed: 05/21/2023]
Abstract
Environmental health promotion interventions may reduce endocrine disruptor (ED) exposure. The PREVED (PREgnancy, preVention, Endocrine Disruptors) project was developed to improve knowledge, to enhance risk perception, and to change exposure behavior. Our objective was to present the phases of the PREVED project using the RE-AIM method. PREVED intervention consisted of three workshops during pregnancy. Reach, adoption, and implementation phases were assessed with qualitative studies. Efficacy study consisted of a three-arm randomized controlled trial (RCT) on 268 pregnant women: (i) control group (leaflet), (ii) intervention group in neutral location, (iii) intervention group in contextualized location. The main outcome was the percentage evolution of participants who reported consuming canned food. Secondary outcomes were evolution of psycho-social scores, evolution of ED presence in urine, and ED presence in colostrum. The intervention adoption was centered on upper-privileged women, but implementation assessment showed that key features (highly practical intervention) seemed to be carried out and had initiated some behavior changes. A total of 268 pregnant women participated in the intervention and 230 in a randomized controlled trial (control group: 86 and intervention groups: 172). We found no significant differences in consumption of canned food and in percentage of women having a decrease of bisphenol A or parabens in urine, but we found a significant increase in the evolution of risk perception score and overall psychosocial score in intervention groups (respectively: +15.73 control versus +21.03 intervention, p = 0.003 and +12.39 versus +16.20, p = 0.02). We found a significant difference in percentage of women with butylparaben detection between control group and intervention groups (13% versus 3%, p = 0.03). PREVED intervention is the first intervention research dedicated to perinatal environmental health education in France. By sharing know-how/experience in a positive non-alarmist approach, it improved risk perception, which is key to behavior change, aiming to reduce perinatal ED exposure. Including women in precarious situations remains a major issue.
Collapse
Affiliation(s)
- Houria El Ouazzani
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Simon Fortin
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
| | - Nicolas Venisse
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Antoine Dupuis
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Steeve Rouillon
- APHP Laboratory of Pharmacology, GH Henri Mondor, 94010 Creteil, France;
| | - Guillaume Cambien
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Anne-Sophie Gourgues
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Pascale Pierre-Eugène
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Sylvie Rabouan
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Virginie Migeot
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Marion Albouy-Llaty
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
- Correspondence:
| |
Collapse
|